Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies

被引：55

作者：

Liu, Qian ^{[1
,2
]}

Zhang, Jing ^{[1
]}

Guo, Chenchen ^{[3
]}

Wang, Mengcheng ^{[3
,4
]}

Wang, Chenfei ^{[5
,6
]}

Yan, Yilv ^{[1
]}

Sun, Liangdong ^{[1
]}

Wang, Di ^{[1
]}

Zhang, Lele ^{[7
]}

Yu, Huansha ^{[1
]}

Hou, Likun ^{[8
]}

Wu, Chunyan ^{[8
]}

Zhu, Yuming ^{[1
]}

Jiang, Gening ^{[1
]}

Zhu, Hongwen

Zhou, Yanting ^{[2
]}

Fang, Shanhua ^{[2
]}

Zhang, Tengfei

Hu, Liang

Li, Junqiang ^{[9
]}

Liu, Yansheng ^{[10
]}

Zhang, Hui ^{[11
]}

Zhang, Bing ^{[12
]}

Ding, Li ^{[13
]}

Robles, Ana I. ^{[14
]}

Rodriguez, Henry ^{[14
]}

Gao, Daming ^{[3
,4
,15
]}

Ji, Hongbin ^{[3
,4
,15
,17
]}

Zhou, Hu ^{[2
,4
,16
]}

Zhang, Peng ^{[1
]}

机构：

[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai 200433, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Dept Analyt Chem, Shanghai 201203, Peoples R China

[3] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, Shanghai 200031, Peoples R China

[4] Univ Chinese Acad Sci, Beijing 100049, Peoples R China

[5] Tongji Univ, Tongji Hosp, Sch Life Sci & Technol, Dept Orthoped,Key Lab Spine & Spinal Cord Injury R, Shanghai 200092, Peoples R China

[6] Tongji Univ, Frontier Sci Ctr Stem Cells, Sch Life Sci & Technol, Shanghai 200092, Peoples R China

[7] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Cent Lab, Shanghai 200433, Peoples R China

[8] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Pathol, Shanghai 200433, Peoples R China

[9] D1 Med Technol, Shanghai 201800, Peoples R China

[10] Yale Univ, Sch Med, Canc Biol Inst, West Haven, CT 06516 USA

[11] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA

[12] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA

[13] Washington Univ, McDonnell Genome Inst, Dept Med, St Louis, MO 63108 USA

[14] NCI, Off Canc Clin Prote Res, NIH, Rockville, MD 20850 USA

[15] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Key Lab Syst Hlth Sci Zhejiang Prov, Hangzhou 310024, Peoples R China

[16] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China

[17] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200120, Peoples R China

来源：

CELL | 2024年 / 187卷 / 01期

基金：

中国博士后科学基金; 中国国家自然科学基金;

关键词：

TO-MESENCHYMAL TRANSITION; DNA-DAMAGE REPAIR; MOLECULAR SIGNATURES; GENOMIC ANALYSIS; READ ALIGNMENT; POOR-PROGNOSIS; AURORA KINASE; MUTATIONS; GENE; PROLIFERATION;

D O I：

10.1016/j.cell.2023.12.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We performed comprehensive proteogenomic characterization of small cell lung cancer (SCLC) using paired tumors and adjacent lung tissues from 112 treatmentnaive patients who underwent surgical resection. Integrated multi-omics analysis illustrated cancer biology downstream of genetic aberrations and highlighted oncogenic roles of FAT1 mutation, RB1 deletion, and chromosome 5q loss. Two prognostic biomarkers, HMGB3 and CASP10, were identified. Overexpression of HMGB3 promoted SCLC cell migration via transcriptional regulation of cell junction-related genes. Immune landscape characterization revealed an association between ZFHX3 mutation and high immune infiltration and underscored a potential immunosuppressive role of elevated DNA damage response activity via inhibition of the cGAS-STING pathway. Multi-omics clustering identified four subtypes with subtype-specific therapeutic vulnerabilities. Cell line and patient-derived xenograft-based drug tests validated the specific therapeutic responses predicted by multi-omics subtyping. This study provides a valuable resource as well as insights to better understand SCLC biology and improve clinical practice.

引用

页码：184 / 203.e28

页数：49

共 50 条

[31] A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Matthew H. Larson
Wenying Pan
Hyunsung John Kim
Ruth E. Mauntz
Sarah M. Stuart
Monica Pimentel
Yiqi Zhou
Per Knudsgaard
Vasiliki Demas
Alexander M. Aravanis
Arash Jamshidi
Nature Communications, 12
[32] A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Larson, Matthew H.
Pan, Wenying
Kim, Hyunsung John
Mauntz, Ruth E.
Stuart, Sarah M.
Pimentel, Monica
Zhou, Yiqi
Knudsgaard, Per
Demas, Vasiliki
Aravanis, Alexander M.
Jamshidi, Arash
NATURE COMMUNICATIONS, 2021, 12 (01)
[33] Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
George, Sally L.
Lynn, Claire
Stankunaite, Reda
Hughes, Debbie
Sauer, Carolin M.
Chalker, Jane
Ahmed, Saira Waqar
Oostveen, Minou
Proszek, Paula Z.
Yuan, Lina
Shaikh, Ridwan
Jamal, Sabri
Brew, Ama
Tall, Jennifer
Rogers, Tony
Clifford, Steven C.
Vormoor, Josef
Shipley, Janet M.
Tweddle, Deborah A.
Jones, Chris
Willis, Courtney
Burke, G. A. Amos
Vedi, Aditi
Howell, Lisa
Johnston, Robert
Rees, Helen
Adams, Madeleine
Jesudason, Angela
Ronghe, Milind
Elliott, Martin
Ross, Emma
Makin, Guy
Campbell-Hewson, Quentin
Grundy, Richard G.
Turnbull, Jennifer
Wilson, Shaun
Lee, Victoria
Gray, Juliet C.
Stoneham, Sara
Gatz, Susanne A.
Marshall, Lynley V.
Angelini, Paola
Anderson, John
Cresswell, George D.
Graham, Trevor A.
Al-Lazikani, Bissan
Cortes-Ciriano, Isidro
Kearns, Pamela
Hutchinson, J. Ciaran
Hargrave, Darren
CANCER DISCOVERY, 2025, 15 (04) : 717 - 732
[34] Association of radiotherapy with the risk of subtype-specific lung cancer among breast cancer survivors in the United States
Jiang, Chenxi
Freedman, Rachel A.
Jemal, Ahmedin
Sung, Hyuna
CANCER RESEARCH, 2024, 84 (07)
[35] Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer
Herbert H. Loong
Sui-chun Sampson Kwan
Tony Shu-kam Mok
Yat-ming Lau
Current Treatment Options in Oncology, 2018, 19
[36] Modern therapeutic strategies for oligometastatic non-small cell lung cancer
Lorenz, Judith
ZENTRALBLATT FUR CHIRURGIE, 2025, 150 (01):
[37] Recent advances in therapeutic strategies for non-small cell lung cancer
Su, Po-Lan
Furuya, Naoki
Asrar, Alahmadi
Rolfo, Christian
Li, Zihai
Carbone, David P.
He, Kai
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2025, 18 (01)
[38] Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer
Loong, Herbert H.
Kwan, Sui-chun Sampson
Mok, Tony Shu-kam
Lau, Yat-ming
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (11)
[39] Transcriptional subtype-specific microenvironmental crosstalk and tumor cell plasticity in metastatic pancreatic cancer
Raghavan, Srivatsan
Winter, Peter S.
Navia, Andrew W.
Williams, Hannah L.
DenAdel, Alan
Kalekar, Radha L.
Galvez-Reyes, Jennyfer
Lowder, Kristen E.
Mulugeta, Nolawit
Raghavan, Manisha S.
Borah, Ashir A.
Vayrynen, Sara A.
Costa, Andressa Dias
Wang, Junning
Reilly, Emma
Ragon, Dorisanne Y.
Brais, Lauren K.
Jaeger, Alex M.
Cleary, James M.
Crawford, Lorin
Nowak, Jonathan A.
Wolpin, Brian M.
Hahn, William C.
Aguirre, Andrew J.
Shalek, Alex K.
CANCER RESEARCH, 2020, 80 (22)
[40] Subtype-specific microenvironmental crosstalk and tumor cell plasticity in metastatic pancreatic cancer.
Winter, Peter S.
Raghavan, Srivatsan
Navia, Andrew
Williams, Hannah
DenAdel, Alan
Kalekar, Radha
Galvez-Reyes, Jennyfer
Lowder, Kristen
Mulugeta, Nolawit
Raghavan, Manisha
Borah, Ashir
Ng, Raymond
Wang, Junning
Reilly, Emma
Ragon, Dorisanne
Brais, Lauren
Ng, Kimmie
Cleary, James
Crawford, Lorin
Manalis, Scott
Nowak, Jonathan
Wolpin, Brian
Hahn, William
Aguirre, Andrew
Shalek, Alex
CANCER RESEARCH, 2020, 80 (21)

← 1 2 3 4 5 →